Market Size of Philippines Diabetes Care Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 4.70 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Philippines Diabetes Care Devices Market Analysis
The Philippines Diabetes Care Devices Market size is expected to grow from USD 80.82 million in the current year to USD 101.68 million by the forecast period, at a CAGR of 4.70% during the forecast period.
COVID-19 is a new illness caused by a strain of the SARS-CoV-2 virus. Most patients infected with the virus will develop mild to moderate respiratory disease and will recover without the need for special care. The elderly and those with underlying medical disorders such as diabetes, hypertension, heart disease, lung disease, obesity, and cancer are more prone to develop serious illnesses. The virus's invasion of different cells in the body, including the heart and lungs, creates inflammatory alterations that cause inflammation and multi-organ damage. Diabetes has been linked to systemic inflammation. Diabetes patients had increased virus entrance, a reduced immune response, less viral clearance, and dysregulated inflammatory markers, according to research.
Patients with diabetes may be at the same risk of getting COVID-19 as those who do not have diabetes. However, due to the disease's fundamental characteristic, people with diabetes have a greater risk of hospitalisation, ICU admissions, severe sequelae, and mortality after contracting COVID -19 than those without diabetes.
Diabetes is a complicated condition defined by high blood sugar levels as a result of impaired insulin production and/or action. Insulin is a pancreatic hormone that controls blood sugar levels in the body. Diabetes uncontrolled causes a variety of consequences, including heart attack, stroke, leg amputation, blindness, and kidney failure. According to DOST-FNRI data, Prediabetes affects around 14.2% of the population. When diabetes and prediabetes are combined, one out of every five Filipinos has abnormal glucose levels.
